Inventor · disambiguated record
Justin W. Conway
Also filed as: CONWAY JUSTIN · CONWAY JUSTIN W
7 granted patents·10 pending applications·19 citations·filing 2015–2024
81Inventor score
Top patents by PatentIndex Score
17 records- 0193US11471406B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2020·Granted Oct 18, 2022·3 cites·20 claims
- 0290US10828254B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2018·Granted Nov 10, 2020·4 cites·20 claims
- 0389US10722476B2Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2018·Granted Jul 28, 2020·3 cites·12 claims
- 0488US11602504B2Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Granted Mar 14, 2023·4 cites·17 claims
- 0586US9949934B1Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2016·Granted Apr 24, 2018·5 cites·3 claims
- 0683US2025120908A1Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2024·Application pending·0 cites
- 0779US12156937B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2022·Granted Dec 3, 2024·0 cites·20 claims
- 0872US2023201130A1Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2023·Application pending·0 cites
- 0967US2022362164A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2022·Application pending·0 cites
- 1067US2022395452A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2022·Application pending·0 cites
- 1161US2019290595A1Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2019·Application pending·0 cites
- 1259US2019133925A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2018·Application pending·0 cites
- 1358US2018250240A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2018·Application pending·0 cites
- 1455US12303501B2Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Granted May 20, 2025·0 cites·20 claims
- 1550US2020138885A1Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Application pending·0 cites
- 1636US2017258710A1Montelukast transmucosal filmINTELGENX CORP·Filed 2016·Application pending·0 cites
- 1732US2019257068A1A system for environmental spills protectionWATERUP PTY LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Justin W. Conway files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →